Poly--Glutamic Acid Attenuates Angiogenesis and Inflammation in Experimental Colitis
Figure 2
Histopathological examination in a γ-PGA-treated DSS-induced colitis model. (a) Colons were obtained 7 days after commencement of DSS administration and then sectioned and stained with hematoxylin and eosin. Control group (without DSS; Cont), 3% DSS administration group (DSS), 3% DSS with γ-PGA at 50 mg/kg body weight per day (D + P50), 3% DSS with γ-PGA at 200 mg/kg body weight per day (D + P200). Original magnification: 40x. (b) Histopathological scores of the analyzed slides. Bars represent the mean ± SD from 3 slides per mouse. *, DSS versus Cont; #, D + P50 and D + P200 versus DSS.
